学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

三井田孝（ミイダタカシ）

研究テーマ	各種病態におけるHDL亜分画の変化
研究業績（論文）	1 教育の内容方法の工夫 6年生の選択実習において、各自が興味を持った検査項目に影響する因子について、自分で実験計画をたたてデータを取るよう改訂した 2 作成した教科書、教材、参考書等（１）心電図演習問題（2003年4月～2008年3月）　実際の患者データから、代表的な心電図異常　（頻度が高いか、頻度が低くても生命にかかわるもの）を　問題形式にまとめた 3 なし 4 その他教育活動上特記すべき事項（１）高校一年生対象のオープンキャンパス（2003～2007年）　医学部に興味のある高校生に検査部を案内し業務を紹介（２）司法修習生に対する医療安全管理の研修（2004年～2007年）　医療安全管理の現状と問題点についての説明と意見交換 5 なし 6 業績 * Publons (Researcher ID A-5589-2012): https://publons.com/researcher/1354319/takashi-miida/ SCOPUS ID (7006100838) http://www.scopus.com/authid/detail.url?authorId=7006100838 Pubmed My Bibliography https://www.ncbi.nlm.nih.gov/myncbi/16YiiHcdx49/bibliography/public/ *ORCID ID (orcid.org/0000-0002-4294-8030) http://orcid.org/0000-0002-4294-8030 　（2018～2023年の英文原著） 1) Kai T, Hirayama S, Soda S, Fuwa F, Nakagawa S, Ueno T, Hori A, Miida T. Higher concentration of 25-hydroxycholesterol in treatment-naïve patients with type 2 diabetes compared to healthy individuals. J Clin Lipidol (in press) 2) Kuwabara N, Fuwa F, Sato S, Hirayama S, Miida T, Nakagawa S. Simultaneous determination of cholesterol precursors, plant sterols, and oxysterols in plasma using one-round pretreatment. Med Mass Spectrom (in press) 3) Sagara R, Hirayama S, Ueno T, Hori A, Kobori Y, Kai T, Nishioka E, Matsukawa T, Makino S, Miida T. Lipoprotein lipase concentration in umbilical cord blood reflects neonatal birth weight. Clin Chim Acta, Vol. 542, 1 March 2023, 117275 4) Tsuchiya K, Kimura K, Ai T, Yamamoto T, Nagasaka K, Takemura H, Saito K, Horiuchi Y, Misawa S, Miida T, Uchihashi K, Tabe Y. Bone marrow aspirate examination using the automated blood cell analyzer Sysmex XN-3000. Int J Lab Hematol (in press) 5) Watanabe J, Ihara H, Takei S, Nakamura A, Fujimoto Y, Handoh T, Kurokawa K, Arai Y, Shibayama K, Sumiyoshi I, Ochi Y, Okabe T, Misawa S, Togo S, Naito T, Tabe Y, Miida T, Takahashi K. The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species. Sci Rep 13: 2027, 2023. 6) Takahashi M, Saito K, Ai T, Nojiri S, Khasawneh A, Paran FJ, Horiuchi Y, Takei S, Yamamoto T, Wakita M, Hiki M, Miida T, Naito T, Takahashi K, Tabe Y. Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment. PLoS One 18: e0279779, 2023. 7) Fukuda N, Balikagala B, Ueno T, Anywar DA, Kimura E, Palacpac NMQ, Odongo-Aginya EI, Ogwang M, Horii T, Miida T, Mita T. The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa. Clin Infect Dis 76: 1585-1593, 2023. 8) Mark Castleberry, Chase A. Raby, Anca Ifrim, Yasuhiro Shibata, Sachi Matsushita, Shinya Ugawa, Yutaka Miura, Atsushi Hori, Takashi Miida, MacRae F. Linton, Danielle L. Michell, Maki Tsujita, Kasey C Vickers. High-density lipoproteins mediate small RNA intercellular communication between dendritic cells and macrophages. J Lipid Res 64: 100328, 2023. 9) Tsuchiya K, Yamamoto N, Hosaka Y, Wakita M, Hiki M, Matsushita Y, Mori H, Hori S, Misawa S, Miida T, Nojiri S, Takahashi K, Naito T, Tabe Y. Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity. Front Microbiol 13: 912061, 2022. 10) Suzuki K, Tange M, Yamagishi R, Hanada H, Mukai S, Sato T, Tanaka T, Akashi T, Kadomatsu K, Maeda T, Miida T, Takeuchi I, Murakami H, Sekido Y, Murakami-Tonami Y. SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma. Cell Death Discov 8: 446, 2022. 11) Takei S, Ai T, Yamamoto T, Igawa G, Kanno T, Tobiume M, Hiki M, Saito K, Khasawneh A, Wakita M, Misawa S, Miida T, Okuzawa A, Suzuki T, Takahashi K, Naito T, Tabe Y. Performance evaluation of the Roche Elecsys ® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment. PLoS One 17: e0274181, 2022. 12) Takahashi M, Ai T, Sinozuka K, Baba Y, Igawa G, Nojiri S, Yamamoto T, Yuri M, Takei S, Saito K, Horiuchi Y, Kanno T, Tobiume M, Khasawneh A, Paran FJ, Hiki M, Wakita M, Miida T, Suzuki T, Okuzawa A, Takahashi K, Naito T, Tabe Y. Activation of SARS-COV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies. Sci Rep 12: 14909, 2022. 13) Takei S, Lu YJ, Tohya M, Watanabe S, Misawa S, Tabe Y, Miida T, Mya S, Tin H, Tada Ta, Kirikae T. Spread of carbapenem-resistant Klebsiella pneumoniae clinical isolates producing NDM-type metallo-β-lactamase in Myanmar. Microbiol Spectr 10: e0067322, 2022. 14) Maki R, Horiuchi Y, Hayashi F, Nojiri S, Takehara I, Iwasaki Y, Miyake K, Miida T, Ai T, Tabe Y. Development of an evaluation model to determine disease severity in COVID-19 using basic laboratory markers. Int J Lab Hematol 44: e245-e249, 2022. 15) Tsuchiya K, Hosaka Y, Takahashi T, Chonan M, Makita Y, Katayama I, Ai T, Idei M, Horiuchi Y, Yamatani K, Wakita M, Misawa S, Okuzawa A, Miida T, Naito T, Takahashi K, Tabe Y. Meals and room temperature storage do not significantly affect feasibility of direct RT-PCR tests for SARS-CoV-2 using saliva. Clin Lab 68: 1113-1119, 2022. 16) Igawa G, Ai T, Yamamoto T, Ito K, Nojiri S, Saito K, Wakita M, Fukuda H, Hori S, Misawa S, Miida T, Seyama K, Takahashi K, Tabe Y, Naito T. Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a university hospital at Tokyo. Sci Rep 12: 8707, 2022. 17) Takamatsu A, Oshiro S, Mizutani N, Tada T, Tabe Y, Miida T, Kirikae T, Tagashira Y. Correlation of COVID-19 severity and immunoglobulin presence against spike and nucleocapsid proteins in SARS-CoV-2. Viral Immunol 35: 1-5, 2022. 18) Idei M, Abe M, Tanaka M, Hamada C, Isshiki M, Nakata J, Suzuki Y, Hino O, Miida T. Effluent N-terminal expressed in renal cell carcinoma/mesothelin predicts increased peritoneal permeability in patients undergoing peritoneal dialysis. Ther Apher Dial 26: 1014-1022, 2022. 19) Oshiro S, Tabe Y, Funatogawa K, Saito K, Tada T, Mizutani N, Akiwa M, Sekiguchi J, Miida T, Kirikae T. Assessment of an immunochromatographic kit for detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses. J Virol Methods 302: 114477, 2022. 20) Yamatani K, Ai T, Saito K, Suzuki K, Hori A, Kinjo S, Ikeo K, Ruvolo V, Zhang W, Mak PY, Kaczkowski B, Harada H, Katayama K, Sugimoto Y, Myslinski J, Hato T, Miida T, Konopleva M, Hayashizaki Y, Carter BZ, Tabe Y, Andreeff M. Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML. Transl Oncol 18: 101354, 2022. 21) Saito K, Ai T, Kawai A, Matsui J, Fukushima Y, Kikukawa N, Kyoutou T, Chonan M, Kawakami T, Hosaka Y, Misawa S, Takagi H, Matsushita Y, Hiki M, Okuzawa A, Hori S, Naito T, Miida T, Takahashi K, Tabe Y. Performance and usefulness of a novel automated immunoassay HISCL SARS-CoV-2 antigen assay kit for the diagnosis of COVID-19. Sci Rep 11: 23196, 2021. 22) Horiuchi Y, Hayashi F, Iwasaki Y, Matsuzaki A, Nishibe K, Marutani S, Matsuoka S, Saito K, Takehara I, Uchihashi K, Miida T, Ai T, Tabe Y. Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID-19. Int J Lab Hematol 43: 1309-1318, 2021. 23) Igawa G, Yamamoto T, Baba Y, Shinozuka K, Yuri M, Wakita M, Misawa S, Miida T, Ai T, Tabe Y. Clinical evaluation of Siemens SARS-CoV-2 total antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo metropolitan area. Heliyon 7: e08393, 2021. 24) Okahara S, Handoh T, Wakita M, Yamamoto T, Misawa S, Miida T, Sumikura H. Fibrinogen measurement by a novel point-of-care device with whole blood: comparison of values against Clauss method. J Anesth 35: 757-760, 2021. 25) Saito K, Zhang Q, Yang H, Yamatani K, Ai T, Ruvolo V, Baran N, Cai T, Ma H, Jacamo R, Kuruvilla VM, Imoto J, Kinjo S, Ikeo K, Moriya K, Suzuki K, Miida T, Kim Y-M, Vellano CP, Andreeff M, Marszalek JR, Tabe Y, Konopleva M. Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. Blood Adv 5: 4233-4255, 2021. 26) Oshiro S, Tabe Y, Funatogawa K, Saito K, Tada T, Hishinuma T, Mizutani N, Akiwa M, Sekiguchi J, Miida T, Kirikae T. Development of an immunochromatographic kit to detect severe acute respiratory syndrome coronavirus 2. J Virol Methods, Vol. 294, 114183, 2021. 27) Kayamori Y, Nakamura M, Kishi K, Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Teramoto T, Yokoyama S. Comparison of the Japan Society of Clinical Chemistry reference method and CDC method for HDL and LDL cholesterol measurements using fresh sera. Pract Lab Med, Vol. 25, ee00228, 2021. 28) Maki R, Tabe Y, Yamamoto T, Takemura H, Sawada T, Esaki T, Higuchi M, Misawa S, Miyake K, Miida T, Nagai Y, Ohsaka A. Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α+. Int J Lab Hematol 43: 588-596, 2021. 29) Mori S, Hori A, Turker I, Inaji M, Bello-Pardo E, Miida T, Otomo Y, Ai T. Abnormal cardiac repolarization after seizure episodes in structural brain diseases: Cardiac manifestation of electrical remodeling in the brain? J Am Heart Assoc 10: e019778, 2021. 30) Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, Matsushita Y, Matsushita M, Wakita M, Misawa S, Idei M, Miida T, Takahashi K, Naito T. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients. PLoS One, Vol. 16, No 4, e0249449, 2021. 31) Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C, Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida T, Sato H, Hattori N, Tabe Y, Takahashi K. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep, Vol. 11, No 1, 8380, 2021. 32) Hori A, Ai T, Isshiki M, Motoi Y, Tabe Y, Yano K, Hattori N, Miida T. Novel variants in the CLCN1, RYR2, and DCTN1 found in elderly Japanese dementia patients: A case series. Geriatrics, Vol. 6, No 1, 14, 2021. 33) Sasano H, Yoshizawa T, Kawakami T, Takahashi T, Suzuki M, Fukui Y, Uehara Y, Arakawa R, Miida T, Hori S, Naito T. Improvements in quality indicators for the treatment of infectious diseases with intervention by an antimicrobial stewardship team. J Hosp Gen Med, Vol. 3, No. 1, 1-10, 2021. 34) Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, Yamamoto T, Igawa G, Hinata M, Kadota K, Kurosawa T, Takahashi S, Saito T, Misawa S, Akazawa T, Naito T, Miida T, Takahashi K, Ai T, Tabe Y. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests. PLoS One, Vol. 16, No. 2, e0246536, 2021. 35) Yamatani K, Hirayama S, Seino U, Hirayama A, Hori A, Suzuki K, Idei M, Kitahara M, Miida T. Preβ1-HDL metabolism is delayed in patients with chronic kidney disease not on hemodialysis. J Clin Lipidol, Vol. 14, No. 5, 730-739, 2020. 36) Hirayama S, Hori A, Isshiki M, Hirayama A, Ueno T, Tamura Y, Kaga H, Watada H, Kawamori R, Miida T. Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle aged Japanese men. J Clin Lipidol, Vol. 14, No. 4, 522-530, 2020. 37) Nishiie-Yano R, Hirayama S, Tamura M, Kanemochi T, Ueno T, Hirayama A, Hori A, Ai T, Hirose N, Miida T. Hemolysis is responsible for elevation of serum iron concentration after regular exercises in Judo athletes. Biol Trace Elem Res, Vol. 197, No. 1, 63-69, 2020. 38) Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Bujo H, Okamura T, Ikewaki K, Shoji T, Miida T, Yoshida M, Kuzuya M, Yamashita S. Reference intervals of serum non-cholesterol sterols by gender in healthy Japanese individuals. J Atheroscler Thromb 27: 409-417, 2020. 39) Someya Y, Tamura Y, Kaga H, Nojiri S, Shimada K, Daida H, Ishijima M, Kaneko K, Aoki S, Miida T, Hirayama S, Konishi S, Hattori N, Motoi Y, Naito H, Kawamori R, Watada H. Cohort profile: skeletal muscle function and need for long-term care in a prospective cohort study of urban elderly people in Japan (the Bunkyo Health Study). BMJ Open 9: e031584, 2019. 40) Yamatani K, Tabe Y, Ai T, Kimura K, Takemura H, Tsuchiya K, Yang H, Konishi A, Uchihashi K, Horii T, Miida T, Ohsaka A: Performance evaluation of the Sysmex DI‐60 overview application for tumor cell detection in body fluid samples. Int J Lab Hematol 41: e134-e138, 2019. 41) Miyazaki T, Nagasaka H, Komatsu H, Inui A, Morioka I, Tsukahara H, Kaji S, Hirayama S, Miida T, Kondou H, Ihara K, Yagi M, Kizaki Z, Bessho K, Kodama T, Iijima K, Yorihuji T, Matsuzaki Y, Honda A. Serum amino acid profiling in citrin-deficient children exhibiting normal liver function during the apparently healthy period. JIMD Reports 43: 53-61, 2019. 42) Yano K, Hirayama S, Misawa N, Furuta A, Ueno T, Motoi Y, Seino U, Ebinuma H, Ikeuchi T, Schneider WJ, Bujo H, Miida T. Soluble LR11 competes with amyloid β in binding to cerebrospinal-fluid–high-density lipoprotein. Clin Chim Acta 489: 29-34, 2019. 43) Tamura M, Hirose N, Miida T, Hirayama S, Ueno T, Tsuzuki T, Yano K, Kanemochi T. Biochemical indicators and systemic reaction times in male judo competitors during regular and pre-competition conditioning periods. Arch Budo 14: 205-212, 2018. 44) Nagasaka H, Morioka I, Takuwa M, Nakacho M, Yoshida M, Ishida A, Hirayama S, Miida T, Tsukahara H, Yorifuji T, Iijima K. Blood asymmetric dimethylarginine and nitrite/nitrate concentrations in short-stature children born small for gestational age with and without growth hormone therapy. J Int Med Res 46: 761-772, 2018. 45) Nagasaka H, Hirano K, Yorifuji T, Komatsu H, Takatani T, Morioka I, Hirayama S, Miida T. Treatment with medium chain fatty acids milk of CD36-deficient preschool children. Nutrition 50: 45-48, 2018. 46) Isshiki M, Hirayama S, Ueno T, Ito M, Furuta A, Yano K, Yamatani K, Sugihara M, Idei M, Miida T. Apolipoproteins C-II and C-III as nutritional markers unaffected by inflammation. Clin Chim Acta 481: 225-230, 2018. 47) Hirayama S, Nagasaka H, Honda A, Komatsu H, Kodama T, Inui A, Morioka I, Kaji S, Ueno T, Ihara K, Yagi M, Kizaki Z, Bessho K, Kondou H, Yorifuji T, Tsukahara H, Iizima K, Miida T. Cholesterol metabolism is enhanced in the liver and brain of children with citrin deficiency. J Clin Endocrinol Metab 103: 2488-2497, 2018. 48) Yamashita Y, Nakada S, Yoshihara T, Nara T, Furuya N, Miida T, Hattori N, Arikawa-Hirasawa E. Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle. Sci Rep 8: 7766, 2018. 49) Sekihara K, Saitoh K, Yang H, Kawashima H, Kazuno S, Kikkawa M, Arai H, Miida T, Hayashi N, Sasai K, Tabe Y. The direct and bystander effects of low-dose radiation on the skin immune system. PLOS ONE 13: e0199117, 2018. 50) Tabe Y, Saitoh K, Yang H, Sekihara K, Yamatani K, Ruvolo V, Taka H, Kaga N, Kikkawa M, Arai H, Miida T, Andreeff M, Spagnuolo PA, Konopleva M. Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine. Sci Rep 8: 16837, 2018. 51) Pang J, Hu M, Lin J, Miida T, Nawawi HM, Park JE, Wu X, Ramli AS, Kim NT, Kwok S, Gonzalez-Santos LE, Su TC, Truong TH, Soran H, Yamashita S, Tomlinson B, Watts GF. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study." BMJ Open 7: e017817, 2017. 52) Ai T, Yuri M, Tabe Y, Kakimoto A, Morishita S, Tsuchiya K, Takamochi K, Kodama Y, Takahashi F, Shigeki M, Horii T, Suzuki K, Takahashi K, Miida T, Ohsaka A. Comparison of the analytical performance between cobas EGFR assay and PCR-clamp method in the detection of EGFR mutations in Japanese non-small cell lung cancer patients. Clin Lab 63: 1021-1026, 2017. 53) Hirayama S, Nagasaka H, Nakagawa S, Takuwa M, Nakacho M, Yorifuji T, Kondou H, Tsukahara H, Morioka I, Ishida A, Yamato S, Miida T. Growth hormone activates hepatic and cerebral cholesterol metabolism in small-for-gestational age children without catch-up growth. J Clin Lipidol 11: 1032-1042, 2017. 54) Sasamoto K, Hirayama S, Kon M, Seino U, Ueno T, Nagao Y, Hirayama A, Isshiki M, Idei M, Yano K, Miida T. Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjects. Clin Chim Acta 470: 56-63, 2017. 55) Miida T, Nishimura K, Hirayama S, Miyamoto Y, Nakamura M, Masuda D, Yamashita S, Ushiyama M, Komori T, Fujita N, Yokoyama S, Teramoto T. Homogeneous assays for LDL-C and HDL-C are reliable in both the postprandial and fasting state. J Atheroscler Thromb 24: 583-599, 2017. 56) Nakagawa T, Hirayama S, Watanabe T, Yokomura M, Kohno M, Sato T, Bujo H, Sato A, Murata M, Miida T for JSCC Kanto Study Group. Triglyceride concentrations should be measured after　elimination of free glycerol to exclude interindividual variations due to adiposity and fasting status. Clin Chem Lab Med 55: e191-e194, 2017. 57) Sekihara K, Saitoh K, Yamamoto S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H, Miida T, Andreeff M, Konopleva M, Tabe Y. Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. Oncotarget 8: 34552-34564, 2017. 58) Nagao Y, Hirayama S, Kon M, Sasamoto K, Sugihara M, Hirayama A, Isshiki M, Seino U, Miyazaki O, Miida T. Current smokers with hyperlipidemia lack elevated preβ1-HDL concentrations. J Clin Lipidol 11: 242-249, 2017. 59) Nagasaka H, Komatsu H, Inui A, Nakacho M, Morioka I, Tsukahara H, Kaji S, Hirayama S, Miida T, Kondou H, Ihara K, Yagi M, Kizaki Z, Bessho K, Kodama T, Iijima K, Saheki T, Yorifuji T, Honda A. Circulating tricarboxylic acid cycle metabolite levels in citrin-deficient children with metabolic adaptation, with and without sodium pyruvate treatment. Mol Genet and Metab 120: 207-212, 2017. 60) Suzuki L, Hirayama S, Fukui M, Sasaki M, Hiroi S, Ayaori M, Terai S, Tozuka M, Watada H, Miida T. Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages. J Clin Lipidol 11: 110-118, 2017. 61) Shoji H, Ikeda N, Kojima C, Kitamura T, Suganuma H, Hisata K, Hirayama S, Ueno T, Miida T, Shimizu T. Relationship between copper and lipids and atherogenic indices soon after birth in Japanese preterm infants of 32–35 weeks. J Dev Orig Health Dis 8: 256-260, 2017. 62) Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma N, Ikeo K, Mogushi K, Shikami M, Ruvolo VR, Ishizawa J, Hail N Jr, Kazuno S, Igarashi M, Matsushita H, Yamanaka Y, Arai H, Nagaoka I, Miida T, Hayashizaki Y, Konopleva M, Andreeff M. Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells. Cancer Research 77: 1453-1464, 2017. （英文症例報告） 1)Ishibashi R, Takemoto M, Tsurutani Y, Kuroda M, Ogawa M, Wakabayashi H, Nagata M, Hattori A, Sakemoto K, Kitamoto T, Maezawa Y, Narita I, Hiroi S, Furuta A, Miida T, Yokote K. Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: a case report and literature review. J Clin Lipidol 12: 888-897, 2018. （英文総説・エディトリアル） 1)Miida T. Blood sampling on admission in patients with acute coronary syndrome (Editorial). J Atheroscler Thromb 30: 1-2, 2023. 2)Kuroda M, Bujo H, Murano T, Yamaguchi T, Ogura M, Ikewaki K, Koseki M, Takeuchi Y, Nakatsuka A, Hori M, Matsuki K, Miida T, Yokoyama S, Wada J, Harada-Shiba M. Current status of familial lecithin cholesterol acyltransferase (LCAT) deficiency in Japan. J Atheroscler Thromb 28: 679-691, 2021. 3)Koyama S, Sekijima Y, Ogura M, Hori M, Matsuki K, Miida T, Harada-Shiba M. Cerebrotendinous xanthomatosis: molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments. J Atheroscler Thromb 28: 905-925, 2021. 4)Miida T, Hirayama S. Controversy over the atherogenicity of lipoprotein-X. Curr Opin Endocrinol Diabetes 26: 117-123, 2019. 5)Watts GF, Ding PYA, George P, Hagger MS, Hu M, Lin J, Lin KK, Marais AD, Miida T, Nawawi HM, Pang J, Park JE, Gonzalez-Santos LE, Su TC, Truong TH, Santos RD, Soran H, Yamashita S, Tomlinson B for the members of the “Ten Countries Study.” Translational research for improving the care of familial hypercholesterolaemia: The “Ten Countries Study” and beyond. J Atheroscler Thromb 23: 891-900, 2016. 6)Hirayama S, Miida T. Small dense LDL: An emerging risk factor for cardiovascular disease. Clin Chim Acta 414: 215-224, 2012. 7)Miida T, Hirayama S. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol 21: 70-75, 2010. 8)Miida T, Takahashi A, Ikeuchi T. Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects, Pharmacol Ther 113: 378-393, 2007. 9)Miida T, Takahashi A, Tanabe N, Ikeuchi T. Can statins really reduce the risk of Alzheimer’s disease and slow its progression? Curr Opin Lipidol 16: 619-623, 2005. 10)Okada M, Matsuto T, Miida T, Obayashi K, Zhu Y, Fueki Y. Lipid analyses for the management of vascular diseases. J Atheroscler Thromb 11: 190-199, 2004. 11)Miida T, Hirayama S, Nakamura Y. Cholesterol-independent effects of statins and its new therapeutic targets: ischemic stroke and dementia. J Atheroscler Thromb 11: 253-264, 2004. （英文著書） 1)Nagasaka H, Tsukahara H, Miida T. Oxidative stress in inherited metabolic diseases. In: Studies on Pediatric Disorders in Applied Basic Research and Clinical Practice. (Tsukahara H., Kaneko K, Eds.), Springer, New York, NY (U.S.A.), p387-404, 2014. 2)Miida T, Hirayama S. Preβ1-HDL: A native lipid-poor HDL, and its potential as a new marker for HDL metabolism (Chapter 12). In: The HDL Handbook - Biological Functions and Clinical Implications -. (Komoda T, Ed), Academic Press, London (UK), Burlington, San Diego (U.S.A.), p243-259, 2010. 3)Obayashi K, Ando Y, Miida T, Masaaki Nakamura, Taro Yamashita, Mitsuharu Ueda, Katsuki Haraoka, HIsayasu Terazaki, Masahiko Okada. Macroscopic assessment of skin venules in patients with familial amyloidotic polyneuropathy (FAP) using near-infrared spectrophotoscopy: As a marker of autonomic dysfunction. In: Amyloid and Amyloidosis (Gilles G, Kyle RA, Skinner M. Eds.), CRC Press, Boca Raton (U.S.A.), p334-336, 2004. 4)Fielding CJ, Fielding PE, Miida T. High density lipoprotein-cell interactions. In: High Density Lipoproteins and Atherosclerosis (Miller NE, Tall AR, Eds.) Excerpta Medica, Amsterdam (the Netherlands), p 145-152, 1992.

研究テーマ

各種病態におけるHDL亜分画の変化

研究業績（論文）

1 教育の内容方法の工夫
6年生の選択実習において、各自が興味を持った検査項目に影響する因子について、自分で実験計画をたたてデータを取るよう改訂した
2 作成した教科書、教材、参考書等
（１）心電図演習問題（2003年4月～2008年3月）
　実際の患者データから、代表的な心電図異常
　（頻度が高いか、頻度が低くても生命にかかわるもの）を
　問題形式にまとめた
3 なし
4 その他教育活動上特記すべき事項
（１）高校一年生対象のオープンキャンパス（2003～2007年）
　医学部に興味のある高校生に検査部を案内し業務を紹介

（２）司法修習生に対する医療安全管理の研修（2004年～2007年）
　医療安全管理の現状と問題点についての説明と意見交換
5 なし
6 業績

* Publons (Researcher ID A-5589-2012): https://publons.com/researcher/1354319/takashi-miida/

*SCOPUS ID (7006100838)
http://www.scopus.com/authid/detail.url?authorId=7006100838

*Pubmed My Bibliography
https://www.ncbi.nlm.nih.gov/myncbi/16YiiHcdx49/bibliography/public/

*ORCID ID (orcid.org/0000-0002-4294-8030)
http://orcid.org/0000-0002-4294-8030
　

（2018～2023年の英文原著）

1) Kai T, Hirayama S, Soda S, Fuwa F, Nakagawa S, Ueno T, Hori A, Miida T. Higher concentration of 25-hydroxycholesterol in treatment-naïve patients with type 2 diabetes compared to healthy individuals. J Clin Lipidol (in press)

2) Kuwabara N, Fuwa F, Sato S, Hirayama S, Miida T, Nakagawa S. Simultaneous determination of cholesterol precursors, plant sterols, and oxysterols in plasma using one-round pretreatment. Med Mass Spectrom (in press)

3) Sagara R, Hirayama S, Ueno T, Hori A, Kobori Y, Kai T, Nishioka E, Matsukawa T, Makino S, Miida T. Lipoprotein lipase concentration in umbilical cord blood reflects neonatal birth weight. Clin Chim Acta, Vol. 542, 1 March 2023, 117275

4) Tsuchiya K, Kimura K, Ai T, Yamamoto T, Nagasaka K, Takemura H, Saito K, Horiuchi Y, Misawa S, Miida T, Uchihashi K, Tabe Y. Bone marrow aspirate examination using the automated blood cell analyzer Sysmex XN-3000. Int J Lab Hematol (in press)

5) Watanabe J, Ihara H, Takei S, Nakamura A, Fujimoto Y, Handoh T, Kurokawa K, Arai Y, Shibayama K, Sumiyoshi I, Ochi Y, Okabe T, Misawa S, Togo S, Naito T, Tabe Y, Miida T, Takahashi K. The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species. Sci Rep 13: 2027, 2023.

6) Takahashi M, Saito K, Ai T, Nojiri S, Khasawneh A, Paran FJ, Horiuchi Y, Takei S, Yamamoto T, Wakita M, Hiki M, Miida T, Naito T, Takahashi K, Tabe Y. Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment. PLoS One 18: e0279779, 2023.

7) Fukuda N, Balikagala B, Ueno T, Anywar DA, Kimura E, Palacpac NMQ, Odongo-Aginya EI, Ogwang M, Horii T, Miida T, Mita T. The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa. Clin Infect Dis 76: 1585-1593, 2023.

8) Mark Castleberry, Chase A. Raby, Anca Ifrim, Yasuhiro Shibata, Sachi Matsushita, Shinya Ugawa, Yutaka Miura, Atsushi Hori, Takashi Miida, MacRae F. Linton, Danielle L. Michell, Maki Tsujita, Kasey C Vickers. High-density lipoproteins mediate small RNA intercellular communication between dendritic cells and macrophages. J Lipid Res 64: 100328, 2023.

9) Tsuchiya K, Yamamoto N, Hosaka Y, Wakita M, Hiki M, Matsushita Y, Mori H, Hori S, Misawa S, Miida T, Nojiri S, Takahashi K, Naito T, Tabe Y. Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity. Front Microbiol 13: 912061, 2022.

10) Suzuki K, Tange M, Yamagishi R, Hanada H, Mukai S, Sato T, Tanaka T, Akashi T, Kadomatsu K, Maeda T, Miida T, Takeuchi I, Murakami H, Sekido Y, Murakami-Tonami Y. SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma. Cell Death Discov 8: 446, 2022.

11) Takei S, Ai T, Yamamoto T, Igawa G, Kanno T, Tobiume M, Hiki M, Saito K, Khasawneh A, Wakita M, Misawa S, Miida T, Okuzawa A, Suzuki T, Takahashi K, Naito T, Tabe Y. Performance evaluation of the Roche Elecsys ® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment. PLoS One 17: e0274181, 2022.

12) Takahashi M, Ai T, Sinozuka K, Baba Y, Igawa G, Nojiri S, Yamamoto T, Yuri M, Takei S, Saito K, Horiuchi Y, Kanno T, Tobiume M, Khasawneh A, Paran FJ, Hiki M, Wakita M, Miida T, Suzuki T, Okuzawa A, Takahashi K, Naito T, Tabe Y. Activation of SARS-COV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies. Sci Rep 12: 14909, 2022.

13) Takei S, Lu YJ, Tohya M, Watanabe S, Misawa S, Tabe Y, Miida T, Mya S, Tin H, Tada Ta, Kirikae T. Spread of carbapenem-resistant Klebsiella pneumoniae clinical isolates producing NDM-type metallo-β-lactamase in Myanmar. Microbiol Spectr 10: e0067322, 2022.

14) Maki R, Horiuchi Y, Hayashi F, Nojiri S, Takehara I, Iwasaki Y, Miyake K, Miida T, Ai T, Tabe Y. Development of an evaluation model to determine disease severity in COVID-19 using basic laboratory markers. Int J Lab Hematol 44: e245-e249, 2022.

15) Tsuchiya K, Hosaka Y, Takahashi T, Chonan M, Makita Y, Katayama I, Ai T, Idei M, Horiuchi Y, Yamatani K, Wakita M, Misawa S, Okuzawa A, Miida T, Naito T, Takahashi K, Tabe Y. Meals and room temperature storage do not significantly affect feasibility of direct RT-PCR tests for SARS-CoV-2 using saliva. Clin Lab 68: 1113-1119, 2022.

16) Igawa G, Ai T, Yamamoto T, Ito K, Nojiri S, Saito K, Wakita M, Fukuda H, Hori S, Misawa S, Miida T, Seyama K, Takahashi K, Tabe Y, Naito T. Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a university hospital at Tokyo. Sci Rep 12: 8707, 2022.

17) Takamatsu A, Oshiro S, Mizutani N, Tada T, Tabe Y, Miida T, Kirikae T, Tagashira Y. Correlation of COVID-19 severity and immunoglobulin presence against spike and nucleocapsid proteins in SARS-CoV-2. Viral Immunol 35: 1-5, 2022.

18) Idei M, Abe M, Tanaka M, Hamada C, Isshiki M, Nakata J, Suzuki Y, Hino O, Miida T. Effluent N-terminal expressed in renal cell carcinoma/mesothelin predicts increased peritoneal permeability in patients undergoing peritoneal dialysis. Ther Apher Dial 26: 1014-1022, 2022.

19) Oshiro S, Tabe Y, Funatogawa K, Saito K, Tada T, Mizutani N, Akiwa M, Sekiguchi J, Miida T, Kirikae T. Assessment of an immunochromatographic kit for detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses. J Virol Methods 302: 114477, 2022.

20) Yamatani K, Ai T, Saito K, Suzuki K, Hori A, Kinjo S, Ikeo K, Ruvolo V, Zhang W, Mak PY, Kaczkowski B, Harada H, Katayama K, Sugimoto Y, Myslinski J, Hato T, Miida T, Konopleva M, Hayashizaki Y, Carter BZ, Tabe Y, Andreeff M. Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML. Transl Oncol 18: 101354, 2022.

21) Saito K, Ai T, Kawai A, Matsui J, Fukushima Y, Kikukawa N, Kyoutou T, Chonan M, Kawakami T, Hosaka Y, Misawa S, Takagi H, Matsushita Y, Hiki M, Okuzawa A, Hori S, Naito T, Miida T, Takahashi K, Tabe Y. Performance and usefulness of a novel automated immunoassay HISCL SARS-CoV-2 antigen assay kit for the diagnosis of COVID-19. Sci Rep 11: 23196, 2021.

22) Horiuchi Y, Hayashi F, Iwasaki Y, Matsuzaki A, Nishibe K, Marutani S, Matsuoka S, Saito K, Takehara I, Uchihashi K, Miida T, Ai T, Tabe Y. Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID-19. Int J Lab Hematol 43: 1309-1318, 2021.

23) Igawa G, Yamamoto T, Baba Y, Shinozuka K, Yuri M, Wakita M, Misawa S, Miida T, Ai T, Tabe Y. Clinical evaluation of Siemens SARS-CoV-2 total antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo metropolitan area. Heliyon 7: e08393, 2021.

24) Okahara S, Handoh T, Wakita M, Yamamoto T, Misawa S, Miida T, Sumikura H. Fibrinogen measurement by a novel point-of-care device with whole blood: comparison of values against Clauss method. J Anesth 35: 757-760, 2021.

25) Saito K, Zhang Q, Yang H, Yamatani K, Ai T, Ruvolo V, Baran N, Cai T, Ma H, Jacamo R, Kuruvilla VM, Imoto J, Kinjo S, Ikeo K, Moriya K, Suzuki K, Miida T, Kim Y-M, Vellano CP, Andreeff M, Marszalek JR, Tabe Y, Konopleva M. Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. Blood Adv 5: 4233-4255, 2021.

26) Oshiro S, Tabe Y, Funatogawa K, Saito K, Tada T, Hishinuma T, Mizutani N, Akiwa M, Sekiguchi J, Miida T, Kirikae T. Development of an immunochromatographic kit to detect severe acute respiratory syndrome coronavirus 2. J Virol Methods, Vol. 294, 114183, 2021.

27) Kayamori Y, Nakamura M, Kishi K, Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Teramoto T, Yokoyama S. Comparison of the Japan Society of Clinical Chemistry reference method and CDC method for HDL and LDL cholesterol measurements using fresh sera. Pract Lab Med, Vol. 25, ee00228, 2021.

28) Maki R, Tabe Y, Yamamoto T, Takemura H, Sawada T, Esaki T, Higuchi M, Misawa S, Miyake K, Miida T, Nagai Y, Ohsaka A. Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α+. Int J Lab Hematol 43: 588-596, 2021.

29) Mori S, Hori A, Turker I, Inaji M, Bello-Pardo E, Miida T, Otomo Y, Ai T. Abnormal cardiac repolarization after seizure episodes in structural brain diseases: Cardiac manifestation of electrical remodeling in the brain? J Am Heart Assoc 10: e019778, 2021.

30) Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, Matsushita Y, Matsushita M, Wakita M, Misawa S, Idei M, Miida T, Takahashi K, Naito T. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients. PLoS One, Vol. 16, No 4, e0249449, 2021.

31) Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C, Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida T, Sato H, Hattori N, Tabe Y, Takahashi K. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep, Vol. 11, No 1, 8380, 2021.

32) Hori A, Ai T, Isshiki M, Motoi Y, Tabe Y, Yano K, Hattori N, Miida T. Novel variants in the CLCN1, RYR2, and DCTN1 found in elderly Japanese dementia patients: A case series. Geriatrics, Vol. 6, No 1, 14, 2021.

33) Sasano H, Yoshizawa T, Kawakami T, Takahashi T, Suzuki M, Fukui Y, Uehara Y, Arakawa R, Miida T, Hori S, Naito T. Improvements in quality indicators for the treatment of infectious diseases with intervention by an antimicrobial stewardship team. J Hosp Gen Med, Vol. 3, No. 1, 1-10, 2021.

34) Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, Yamamoto T, Igawa G, Hinata M, Kadota K, Kurosawa T, Takahashi S, Saito T, Misawa S, Akazawa T, Naito T, Miida T, Takahashi K, Ai T, Tabe Y. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests. PLoS One, Vol. 16, No. 2, e0246536, 2021.

35) Yamatani K, Hirayama S, Seino U, Hirayama A, Hori A, Suzuki K, Idei M, Kitahara M, Miida T. Preβ1-HDL metabolism is delayed in patients with chronic kidney disease not on hemodialysis. J Clin Lipidol, Vol. 14, No. 5, 730-739, 2020.

36) Hirayama S, Hori A, Isshiki M, Hirayama A, Ueno T, Tamura Y, Kaga H, Watada H, Kawamori R, Miida T. Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle aged Japanese men. J Clin Lipidol, Vol. 14, No. 4, 522-530, 2020.

37) Nishiie-Yano R, Hirayama S, Tamura M, Kanemochi T, Ueno T, Hirayama A, Hori A, Ai T, Hirose N, Miida T. Hemolysis is responsible for elevation of serum iron concentration after regular exercises in Judo athletes. Biol Trace Elem Res, Vol. 197, No. 1, 63-69, 2020.

38) Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Bujo H, Okamura T, Ikewaki K, Shoji T, Miida T, Yoshida M, Kuzuya M, Yamashita S. Reference intervals of serum non-cholesterol sterols by gender in healthy Japanese individuals. J Atheroscler Thromb 27: 409-417, 2020.

39) Someya Y, Tamura Y, Kaga H, Nojiri S, Shimada K, Daida H, Ishijima M, Kaneko K, Aoki S, Miida T, Hirayama S, Konishi S, Hattori N, Motoi Y, Naito H, Kawamori R, Watada H. Cohort profile: skeletal muscle function and need for long-term care in a prospective cohort study of urban elderly people in Japan (the Bunkyo Health Study). BMJ Open 9: e031584, 2019.

40) Yamatani K, Tabe Y, Ai T, Kimura K, Takemura H, Tsuchiya K, Yang H, Konishi A, Uchihashi K, Horii T, Miida T, Ohsaka A: Performance evaluation of the Sysmex DI‐60 overview application for tumor cell detection in body fluid samples. Int J Lab Hematol 41: e134-e138, 2019.

41) Miyazaki T, Nagasaka H, Komatsu H, Inui A, Morioka I, Tsukahara H, Kaji S, Hirayama S, Miida T, Kondou H, Ihara K, Yagi M, Kizaki Z, Bessho K, Kodama T, Iijima K, Yorihuji T, Matsuzaki Y, Honda A. Serum amino acid profiling in citrin-deficient children exhibiting normal liver function during the apparently healthy period. JIMD Reports 43: 53-61, 2019.

42) Yano K, Hirayama S, Misawa N, Furuta A, Ueno T, Motoi Y, Seino U, Ebinuma H, Ikeuchi T, Schneider WJ, Bujo H, Miida T. Soluble LR11 competes with amyloid β in binding to cerebrospinal-fluid–high-density lipoprotein. Clin Chim Acta 489: 29-34, 2019.

43) Tamura M, Hirose N, Miida T, Hirayama S, Ueno T, Tsuzuki T, Yano K, Kanemochi T. Biochemical indicators and systemic reaction times in male judo competitors during regular and pre-competition conditioning periods. Arch Budo 14: 205-212, 2018.

44) Nagasaka H, Morioka I, Takuwa M, Nakacho M, Yoshida M, Ishida A, Hirayama S, Miida T, Tsukahara H, Yorifuji T, Iijima K. Blood asymmetric dimethylarginine and nitrite/nitrate concentrations in short-stature children born small for gestational age with and without growth hormone therapy. J Int Med Res 46: 761-772, 2018.

45) Nagasaka H, Hirano K, Yorifuji T, Komatsu H, Takatani T, Morioka I, Hirayama S, Miida T. Treatment with medium chain fatty acids milk of CD36-deficient preschool children. Nutrition 50: 45-48, 2018.

46) Isshiki M, Hirayama S, Ueno T, Ito M, Furuta A, Yano K, Yamatani K, Sugihara M, Idei M, Miida T. Apolipoproteins C-II and C-III as nutritional markers unaffected by inflammation. Clin Chim Acta 481: 225-230, 2018.

47) Hirayama S, Nagasaka H, Honda A, Komatsu H, Kodama T, Inui A, Morioka I, Kaji S, Ueno T, Ihara K, Yagi M, Kizaki Z, Bessho K, Kondou H, Yorifuji T, Tsukahara H, Iizima K, Miida T. Cholesterol metabolism is enhanced in the liver and brain of children with citrin deficiency. J Clin Endocrinol Metab 103: 2488-2497, 2018.

48) Yamashita Y, Nakada S, Yoshihara T, Nara T, Furuya N, Miida T, Hattori N, Arikawa-Hirasawa E. Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle. Sci Rep 8: 7766, 2018.

49) Sekihara K, Saitoh K, Yang H, Kawashima H, Kazuno S, Kikkawa M, Arai H, Miida T, Hayashi N, Sasai K, Tabe Y. The direct and bystander effects of low-dose radiation on the skin immune system. PLOS ONE 13: e0199117, 2018.

50) Tabe Y, Saitoh K, Yang H, Sekihara K, Yamatani K, Ruvolo V, Taka H, Kaga N, Kikkawa M, Arai H, Miida T, Andreeff M, Spagnuolo PA, Konopleva M. Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine. Sci Rep 8: 16837, 2018.

51) Pang J, Hu M, Lin J, Miida T, Nawawi HM, Park JE, Wu X, Ramli AS, Kim NT, Kwok S, Gonzalez-Santos LE, Su TC, Truong TH, Soran H, Yamashita S, Tomlinson B, Watts GF. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study." BMJ Open 7: e017817, 2017.

52) Ai T, Yuri M, Tabe Y, Kakimoto A, Morishita S, Tsuchiya K, Takamochi K, Kodama Y, Takahashi F, Shigeki M, Horii T, Suzuki K, Takahashi K, Miida T, Ohsaka A. Comparison of the analytical performance between cobas EGFR assay and PCR-clamp method in the detection of EGFR mutations in Japanese non-small cell lung cancer patients. Clin Lab 63: 1021-1026, 2017.

53) Hirayama S, Nagasaka H, Nakagawa S, Takuwa M, Nakacho M, Yorifuji T, Kondou H, Tsukahara H, Morioka I, Ishida A, Yamato S, Miida T. Growth hormone activates hepatic and cerebral cholesterol metabolism in small-for-gestational age children without catch-up growth. J Clin Lipidol 11: 1032-1042, 2017.

54) Sasamoto K, Hirayama S, Kon M, Seino U, Ueno T, Nagao Y, Hirayama A, Isshiki M, Idei M, Yano K, Miida T. Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjects. Clin Chim Acta 470: 56-63, 2017.

55) Miida T, Nishimura K, Hirayama S, Miyamoto Y, Nakamura M, Masuda D, Yamashita S, Ushiyama M, Komori T, Fujita N, Yokoyama S, Teramoto T. Homogeneous assays for LDL-C and HDL-C are reliable in both the postprandial and fasting state. J Atheroscler Thromb 24: 583-599, 2017.

56) Nakagawa T, Hirayama S, Watanabe T, Yokomura M, Kohno M, Sato T, Bujo H, Sato A, Murata M, Miida T for JSCC Kanto Study Group. Triglyceride concentrations should be measured after　elimination of free glycerol to exclude interindividual variations due to adiposity and fasting status. Clin Chem Lab Med 55: e191-e194, 2017.

57) Sekihara K, Saitoh K, Yamamoto S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H, Miida T, Andreeff M, Konopleva M, Tabe Y. Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. Oncotarget 8: 34552-34564, 2017.

58) Nagao Y, Hirayama S, Kon M, Sasamoto K, Sugihara M, Hirayama A, Isshiki M, Seino U, Miyazaki O, Miida T. Current smokers with hyperlipidemia lack elevated preβ1-HDL concentrations. J Clin Lipidol 11: 242-249, 2017.

59) Nagasaka H, Komatsu H, Inui A, Nakacho M, Morioka I, Tsukahara H, Kaji S, Hirayama S, Miida T, Kondou H, Ihara K, Yagi M, Kizaki Z, Bessho K, Kodama T, Iijima K, Saheki T, Yorifuji T, Honda A. Circulating tricarboxylic acid cycle metabolite levels in citrin-deficient children with metabolic adaptation, with and without sodium pyruvate treatment. Mol Genet and Metab 120: 207-212, 2017.

60) Suzuki L, Hirayama S, Fukui M, Sasaki M, Hiroi S, Ayaori M, Terai S, Tozuka M, Watada H, Miida T. Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages. J Clin Lipidol 11: 110-118, 2017.

61) Shoji H, Ikeda N, Kojima C, Kitamura T, Suganuma H, Hisata K, Hirayama S, Ueno T, Miida T, Shimizu T. Relationship between copper and lipids and atherogenic indices soon after birth in Japanese preterm infants of 32–35 weeks. J Dev Orig Health Dis 8: 256-260, 2017.

62) Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma N, Ikeo K, Mogushi K, Shikami M, Ruvolo VR, Ishizawa J, Hail N Jr, Kazuno S, Igarashi M, Matsushita H, Yamanaka Y, Arai H, Nagaoka I, Miida T, Hayashizaki Y, Konopleva M, Andreeff M. Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells. Cancer Research 77: 1453-1464, 2017.

（英文症例報告）

1)Ishibashi R, Takemoto M, Tsurutani Y, Kuroda M, Ogawa M, Wakabayashi H, Nagata M, Hattori A, Sakemoto K, Kitamoto T, Maezawa Y, Narita I, Hiroi S, Furuta A, Miida T, Yokote K. Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: a case report and literature review. J Clin Lipidol 12: 888-897, 2018.

（英文総説・エディトリアル）

1)Miida T. Blood sampling on admission in patients with acute coronary syndrome (Editorial). J Atheroscler Thromb 30: 1-2, 2023.

2)Kuroda M, Bujo H, Murano T, Yamaguchi T, Ogura M, Ikewaki K, Koseki M, Takeuchi Y, Nakatsuka A, Hori M, Matsuki K, Miida T, Yokoyama S, Wada J, Harada-Shiba M. Current status of familial lecithin cholesterol acyltransferase (LCAT) deficiency in Japan. J Atheroscler Thromb 28: 679-691, 2021.

3)Koyama S, Sekijima Y, Ogura M, Hori M, Matsuki K, Miida T, Harada-Shiba M. Cerebrotendinous xanthomatosis: molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments. J Atheroscler Thromb 28: 905-925, 2021.

4)Miida T, Hirayama S. Controversy over the atherogenicity of lipoprotein-X. Curr Opin Endocrinol Diabetes 26: 117-123, 2019.

5)Watts GF, Ding PYA, George P, Hagger MS, Hu M, Lin J, Lin KK, Marais AD, Miida T, Nawawi HM, Pang J, Park JE, Gonzalez-Santos LE, Su TC, Truong TH, Santos RD, Soran H, Yamashita S, Tomlinson B for the members of the “Ten Countries Study.” Translational research for improving the care of familial hypercholesterolaemia: The “Ten Countries Study” and beyond. J Atheroscler Thromb 23: 891-900, 2016.

6)Hirayama S, Miida T. Small dense LDL: An emerging risk factor for cardiovascular disease. Clin Chim Acta 414: 215-224, 2012.

7)Miida T, Hirayama S. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol 21: 70-75, 2010.

8)Miida T, Takahashi A, Ikeuchi T. Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects, Pharmacol Ther 113: 378-393, 2007.

9)Miida T, Takahashi A, Tanabe N, Ikeuchi T. Can statins really reduce the risk of Alzheimer’s disease and slow its progression? Curr Opin Lipidol 16: 619-623, 2005.

10)Okada M, Matsuto T, Miida T, Obayashi K, Zhu Y, Fueki Y. Lipid analyses for the management of vascular diseases. J Atheroscler Thromb 11: 190-199, 2004.

11)Miida T, Hirayama S, Nakamura Y. Cholesterol-independent effects of statins and its new therapeutic targets: ischemic stroke and dementia. J Atheroscler Thromb 11: 253-264, 2004.

（英文著書）

1)Nagasaka H, Tsukahara H, Miida T. Oxidative stress in inherited metabolic diseases. In: Studies on Pediatric Disorders in Applied Basic Research and Clinical Practice. (Tsukahara H., Kaneko K, Eds.), Springer, New York, NY (U.S.A.), p387-404, 2014.

2)Miida T, Hirayama S. Preβ1-HDL: A native lipid-poor HDL, and its potential as a new marker for HDL metabolism (Chapter 12). In: The HDL Handbook - Biological Functions and Clinical Implications -. (Komoda T, Ed), Academic Press, London (UK), Burlington, San Diego (U.S.A.), p243-259, 2010.

3)Obayashi K, Ando Y, Miida T, Masaaki Nakamura, Taro Yamashita, Mitsuharu Ueda, Katsuki Haraoka, HIsayasu Terazaki, Masahiko Okada. Macroscopic assessment of skin venules in patients with familial amyloidotic polyneuropathy (FAP) using near-infrared spectrophotoscopy: As a marker of autonomic dysfunction. In: Amyloid and Amyloidosis (Gilles G, Kyle RA, Skinner M. Eds.), CRC Press, Boca Raton (U.S.A.), p334-336, 2004.

4)Fielding CJ, Fielding PE, Miida T. High density lipoprotein-cell interactions. In: High Density Lipoproteins and Atherosclerosis (Miller NE, Tall AR, Eds.) Excerpta Medica, Amsterdam (the Netherlands), p 145-152, 1992.

研究者

教育活動

researchmap(JST)

ホームページURL

【学校法人順天堂】研究者情報データベース

研究業績詳細

三井田 孝（ミイダ タカシ）

三井田孝（ミイダタカシ）